Articles tagged "Economics"

2018 American Transplant Congress
Deceased Donor Initiated Kidney Transplant Exchanges and the Forgotten Incompatible Directed Donor Recipients
E. Molmenti,¹ C. Molmenti,² E. Grodstein,¹ H. Rilo,¹ L. Teperman.¹
¹Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY; ²Feinstein Institute, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY.
Although incompatibility is usually viewed as affecting potential recipients of live donors, it is also encountered in instances of directed donation of deceased donors. In…
2018 American Transplant Congress
Evaluation and Cost Burden of Inappropriately Drawn Immunosuppression Trough Levels in the Acute Care Setting at an Academic Medical Center
A. Brown, J. Geyston, A. Agarwal, B. Jones, W. Ally.
University of Virginia Health System, Charlottesville, VA.
Trough drug levels in narrow therapeutic index medications, such as CNI and mTOR inhibitors are used to estimate total drug exposure. Inappropriately measured trough levels…
2018 American Transplant Congress
Variation in Cost of Death and Graft Failure across All Solid Organs
M. Schnitzler,^1,2 M. Skeans,² D. Axelrod,³ K. Lentine,¹ H. Randall.¹
¹St. Louis Univ, St. Louis, MO; ²SRTR, Minneapolis, MN; ³Lahey Hosp & Med Ctr, Burlington, VT.
Medicare costs for transplant vary considerably by organ, and costs in the second posttransplant year (Y2) are lower than in the first (Y1). Variability in…
2018 American Transplant Congress
Overcoming Barriers to Transplant: An A2 to B Program Need Not Be Difficult, Expensive, or Time Consuming Even for Large Centers
S. Radomski, B. Diedrich, D. Li, M. Awwad, S. Rosen-Bronson, A. Langeberg, A-.A. Hamby, M. Cooper, A. Gilbert.
Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.
Introduction. Since the implementation of the new Kidney Allocation System (KAS) few centers have implemented the use of A2 donor kidneys into B recipients. Centers…
2018 American Transplant Congress
Cost Effectiveness of Lifelong Medicare Immunosuppressant Drug Coverage for Kidney Transplant Recipients in the Current Era
M. Kadatz,¹ J. Gill,² J. Gill,² K. Scott.³
¹Clinician Investigator Program, University of British Columbia, Vancouver, BC, Canada; ²Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; ³Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
While there is no Medicare time limit for dialysis patients, kidney transplant recipients lose their Medicare coverage 36 months after they receive their transplant. The…
2018 American Transplant Congress
Treatment Patterns and Burden among Chronic Graft versus Host Disease Patients on Second-Line Systemic Treatments Including Extracorporeal Photopheresis
X. Huang,² N. Joshi,¹ L. Luo,¹ G. Mitri,³ B. Lovelace,² A. Pham,³ X. Gao.¹
¹Pharmerit International, Bethesda, MD; ²Mallinckrodt Pharmaceuticals, Bedminster, NJ; ³Formerly of Mallinckrodt Pharmaceuticals, Bedminster, NJ.
Extracorporeal Photopheresis (ECP) is a cell-based immunomodulatory therapeutic procedure reimbursable by the Centers for Medicare and Medicaid Services for patients with chronic Graft versus Host…
2018 American Transplant Congress
The Living Donor Lost Wages Trial: Study Rationale, Protocol, and Update
J. Rodrigue,¹ M. Pavlakis,¹ A. Evenson,¹ A. Fleishman,¹ M. Carroll,¹ D. Mandelbrot,² P. Baliga,³ D. Howard,⁴ J. Schold.⁵
¹Beth Israel Deaconess Medical Center, Boston, MA; ²University of Wisconsin, Madison, WI; ³Medical University of South Carolina, Charleston, SC; ⁴Emory University, Atlanta, GA; ⁵Cleveland Clinic, Cleveland, OH.
Living donor kidney transplantation (LDKT) is the optimal treatment for adults with renal failure. However, living kidney donation has declined in the past decade, particularly…
2018 American Transplant Congress
Evaluation of Financial Well-Being of Living Kidney Donor Candidates
S. Singh,^1,2 G. Bannerman,² A. Yantsis,² M. Liu,² F. Gumabay,² O. Famure.²
¹Division of Nephrology, Department of Medicine, University of Toronto, Toronto, ON, Canada; ²Division of Nephrology and the Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
Despite the known benefits of living donor kidney transplantation, the rate of living kidney donation in Canada has not increased. Potential reasons include the lack…
2018 American Transplant Congress
Cost Impacts of Alternative Kidney Transplant Immunosuppression: A National Cohort Study
K. Lentine,¹ D. Axelrod,² V. Dharnidharka,³ H. Xiao,¹ D. Brennan,⁴ D. Segev,⁴ H. Randall,¹ R. Ouseph,¹ A. Naik,⁵ N. Lam,⁶ T. Alhamad,³ B. Kasiske,⁷ G. Hess,⁸ M. Schnitzler.¹
¹Saint Louis Univ, St. Louis; ²Lahey Clinic, Burlington; ³Washington Univ, St. Louis; ⁴Johns Hopkins, Baltimore; ⁵Univ Michigan, Ann Arbor; ⁶Univ Alberta, Edmonton, Canada; ⁷Hennepin County, Minneapolis; ⁸Symphony Health, Conshohocken.
Economic outcomes are increasingly considered along with clinical efficacy to guide choice of alternative therapies. We examined the cost impact of kidney transplant (KTx) induction…
2018 American Transplant Congress
Occupational and Financial Outcomes of Directed and Non-Directed Living Liver Donors
J. Steel, M. Dulovich, K. Kingsley, S. Ganesh, O. Ola, A. Lai, S. Shen, N. Zharichenko, S. Nawaz, A. Tevar, C. Hughes, A. Humar.
Surgery, University of Pittsburgh, Pittsburgh, PA.
Background: Few transplant centers accept directed and non-directed living liver donors. The aims of this study were to compare the occupational and financial outcomes of…